JP2017189179A5 - - Google Patents

Download PDF

Info

Publication number
JP2017189179A5
JP2017189179A5 JP2017146473A JP2017146473A JP2017189179A5 JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5 JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5
Authority
JP
Japan
Prior art keywords
cell
host cell
virus
bacterial
bacterial dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017146473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017189179A (ja
JP6666311B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017189179A publication Critical patent/JP2017189179A/ja
Publication of JP2017189179A5 publication Critical patent/JP2017189179A5/ja
Application granted granted Critical
Publication of JP6666311B2 publication Critical patent/JP6666311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017146473A 2009-07-31 2017-07-28 逆遺伝学系 Active JP6666311B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27315109P 2009-07-31 2009-07-31
US61/273,151 2009-07-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012522275A Division JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系

Publications (3)

Publication Number Publication Date
JP2017189179A JP2017189179A (ja) 2017-10-19
JP2017189179A5 true JP2017189179A5 (cg-RX-API-DMAC7.html) 2018-02-01
JP6666311B2 JP6666311B2 (ja) 2020-03-13

Family

ID=43018886

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012522275A Withdrawn JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系
JP2015215655A Pending JP2016019547A (ja) 2009-07-31 2015-11-02 逆遺伝学系
JP2017146473A Active JP6666311B2 (ja) 2009-07-31 2017-07-28 逆遺伝学系

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012522275A Withdrawn JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系
JP2015215655A Pending JP2016019547A (ja) 2009-07-31 2015-11-02 逆遺伝学系

Country Status (8)

Country Link
US (2) US9821052B2 (cg-RX-API-DMAC7.html)
EP (1) EP2459722B1 (cg-RX-API-DMAC7.html)
JP (3) JP2013500712A (cg-RX-API-DMAC7.html)
KR (1) KR20120039047A (cg-RX-API-DMAC7.html)
CN (2) CN104862335A (cg-RX-API-DMAC7.html)
AU (1) AU2010277310B2 (cg-RX-API-DMAC7.html)
CA (1) CA2769673A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011012999A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323582B1 (ko) 2011-03-17 2013-10-30 충북대학교 산학협력단 Vero 세포 유래의 polⅠ 프로모터 및 이를 포함하는 재조합 벡터
WO2013101783A2 (en) 2011-12-30 2013-07-04 Bio-Rad Laboratories, Inc. Methods and compositions for performing nucleic acid amplification reactions
WO2013087945A2 (en) 2012-03-02 2013-06-20 Novartis Ag Influenza virus reassortment
US9708585B2 (en) 2012-12-03 2017-07-18 Seqirus UK Limited Influenza virus reassortment
EP2948175A1 (en) * 2013-01-23 2015-12-02 Novartis AG Influenza virus reassortment
US20140274806A1 (en) 2013-03-15 2014-09-18 Synthetic Genomics Vaccines Influenza virus reassortment
EP2968512A2 (en) 2013-03-13 2016-01-20 Novartis AG Influenza b virus reassortment
US10434166B2 (en) 2013-03-15 2019-10-08 University Of Maryland, College Park Methods and compositions for in vivo immune stimulation and antigen production
DE202013005100U1 (de) 2013-06-05 2013-08-26 Novartis Ag Influenza Virus Reassortierung
DE202013005130U1 (de) 2013-06-05 2013-09-10 Novartis Ag Influenza Virus Reassortierung
AU2014276418A1 (en) 2013-06-06 2016-01-21 Novartis Ag Influenza virus reassortment
CA2980847C (en) * 2015-03-27 2020-03-24 Cadila Healthcare Limited Recombinant mumps virus jeryl lynn 2 based vaccine
US10726110B2 (en) * 2017-03-01 2020-07-28 Seven Bridges Genomics, Inc. Watermarking for data security in bioinformatic sequence analysis
AU2018357917B2 (en) 2017-10-30 2024-08-01 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses
US12305192B2 (en) 2019-06-21 2025-05-20 Osaka University Method for producing artificial recombinant RNA virus stably retaining foreign gene
CN110305854B (zh) * 2019-07-18 2023-09-15 山东中医药大学 一种携带荧光素酶的重组h3n2亚型流感病毒、构建方法及应用
US20230000971A1 (en) 2019-11-18 2023-01-05 Seqirus Pty Ltd. Method for producing reassortant influenza viruses
CN114395568A (zh) * 2021-10-29 2022-04-26 扬州大学 一种猪流行性腹泻病毒感染性cDNA克隆及其构建方法与应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
TW570803B (en) 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
AU3353599A (en) 1998-03-31 1999-10-18 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
EP1086207B1 (en) 1998-06-12 2007-01-17 Mount Sinai School Of Medicine Of The City University Of New York Novel methods and interferon deficient substrates for the propagation of viruses
PT1098961E (pt) 1998-06-12 2008-04-23 Mount Sinai School Of Med Of T Vírus atenuados produzidos por engenharia genética indutores de interferão
GB9916794D0 (en) * 1999-07-16 1999-09-22 Isis Innovation In vitro virus reconstitution
IL148673A0 (en) 1999-09-24 2002-09-12 Smithkline Beecham Biolog Intranasal influenza virus vaccine
US6825036B2 (en) 2000-03-03 2004-11-30 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
SI1317559T1 (sl) 2000-04-28 2009-04-30 St Jude Childrens Res Hospital Sistem transfekcije dna za pripravo infektivne negativne verige virusne rna
AU2001264802A1 (en) 2000-05-21 2001-12-03 University Of North Carolina At Chapel Hill Assembly of large viral genomes and chromosomes from subclones
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
EP2281573A3 (en) 2001-02-23 2011-12-07 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
WO2002067983A1 (en) 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Novel vaccine
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
WO2004022760A1 (en) * 2002-09-04 2004-03-18 Polymun Scientific Immunbiologische Forschung Gmbh Generation of recombinant influenza virus using baculovirus delivery vector
PL1742659T3 (pl) 2004-04-05 2013-08-30 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie oraz kompozycje szczepionek
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
AU2005245943A1 (en) 2004-05-20 2005-12-01 Id Biomedical Corporation Process for the production of an influenza vaccine
MX2007005818A (es) * 2004-11-19 2007-07-20 Wisconsin Alumni Res Found Vectores recombinantes de la influenza con unidades de transcripcion en tandem.
EP2368975B1 (en) 2004-12-23 2014-09-17 MedImmune, LLC Non-tumorigenic MDCK cell line for propagating viruses
RU2435855C2 (ru) 2004-12-24 2011-12-10 Солвей Байолоджикалз Б.В. Способ продуцирования репликативной частицы вируса гриппа, композиция клеток (варианты), композиция клеточной культуры и ее применение
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
EP1917361A4 (en) 2005-06-21 2009-07-29 Medimmune Vaccines Inc METHODS AND COMPOSITIONS FOR EXPRESSING NEGATIVE SENSE RNA VIRUS IN CANINE CELLS
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
CN104474543A (zh) 2005-11-01 2015-04-01 诺华疫苗和诊断有限两合公司 经由β-丙内酯处理的残留细胞DNA水平降低的细胞衍生病毒疫苗
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
AU2007240448B8 (en) 2006-04-19 2014-03-06 Medimmune Llc. Methods and compositions for expressing negative-sense viral RNA in canine cells
CN101522218B (zh) 2006-10-12 2012-09-26 葛兰素史密丝克莱恩生物有限公司 包含水包油乳液佐剂的疫苗
EP2121011B1 (en) 2006-12-06 2014-05-21 Novartis AG Vaccines including antigen from four strains of influenza virus
EP2045323A1 (en) * 2007-10-05 2009-04-08 Avir Green Hills Biotechnology Research Development Trade Ag Linear expression constructs for production of influenza virus particles
EP2207899B1 (en) * 2007-10-08 2018-04-18 Synthetic Genomics, Inc. Assembly of large nucleic acids
CN101302499A (zh) * 2008-06-30 2008-11-12 中国科学院广州生物医药与健康研究院 一种流感病毒疫苗种子株的制备方法
EP2233568A1 (en) * 2009-03-19 2010-09-29 Avir Green Hills Biotechnology Research Development Trade AG Novel method for generation of RNA virus

Similar Documents

Publication Publication Date Title
JP2017189179A5 (cg-RX-API-DMAC7.html)
Kobayashi et al. An improved reverse genetics system for mammalian orthoreoviruses
JP2015119730A5 (cg-RX-API-DMAC7.html)
Zhou et al. Characterization of uncultivable bat influenza virus using a replicative synthetic virus
JP2019011344A5 (cg-RX-API-DMAC7.html)
Sun et al. Rapid construction of complex plant RNA virus infectious cDNA clones for agroinfection using a yeast-E. coli-Agrobacterium shuttle vector
Zhang et al. Wheat yellow mosaic virus NIb interacting with host light induced protein (LIP) facilitates its infection through perturbing the abscisic acid pathway in wheat
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
JP2016521553A5 (cg-RX-API-DMAC7.html)
JP2010042030A5 (cg-RX-API-DMAC7.html)
RU2008101367A (ru) Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках
RU2008145226A (ru) Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
Griffin et al. Fitness determinants of influenza A viruses
CA2968430C (en) Plasmids and method for obtaining viral particles
JP2016501020A5 (cg-RX-API-DMAC7.html)
Mostafa et al. Efficient generation of recombinant influenza a viruses employing a new approach to overcome the genetic instability of HA segments
Zhang et al. Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid
Shao et al. An efficient and rapid influenza gene cloning strategy for reverse genetics system
Lee Reverse genetics of influenza virus
WO2013030176A3 (en) Live attenuated influenza virus
Feng et al. Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression
Park et al. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A (H7N9) virus in guinea pigs
CN104195154A (zh) 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用
Froggatt et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity
CN105671002B (zh) H9n2亚型禽流感病毒细胞高产疫苗株构建及应用